跳至主要内容
临床试验/DRKS00021085
DRKS00021085招募中不适用

Optimization of therapy strategies for intestinal failure

niversitätsmedizin RostockAbteilung für Gastroenterologie, Endokrinologie und Stoffwechselkrankheiten0 个研究点目标入组 100 人开始时间: 2020年4月3日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 one(—)
性别
All

入选标准

  • Patients with intestinal failure and parenteral support

排除标准

  • Age < 18 Years

研究者

发起方
niversitätsmedizin RostockAbteilung für Gastroenterologie, Endokrinologie und Stoffwechselkrankheiten

相似试验

进行中(未招募)
不适用
A Treatment Protocol for Patients with Gastrointestinal Stromal Tumor who are Ineligible for Participation in Other SU011248 Protocols AND are Refractory to or Intolerant of Imatinib Mesylate.Gastro-intestinal Stromal TumorsMedDRA version: 14.1Level: PTClassification code 10051066Term: Gastrointestinal stromal tumourSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)
EUCTR2004-001860-27-ITPFIZER1,098
招募中
不适用
Optimization of systemic treatment strategies in elderly patients with advanced solid malignancies: OptiMal trialadvanced cancerpalliative chemotherapy10027476
NL-OMON47698Vrije Universiteit Medisch Centrum85
未知
不适用
Clinical trial treatment of intestinal failure and parenteral nutrition associated liver disease using an omega-3 fatty acid (fish oil) based intravenous fat emulsion, OMEGAVEintestinal failure and parenteral nutrition associated liver disease
JPRN-UMIN000001914Tohoku University Hospital10
已完成
不适用
A prospective evaluation of the use of intestinal ultrasound as an assessment tool in predicting the course of intestinal inflammation and response to therapy in patients with inflammatory bowel diseaseinflammatory bowel diseaseOral and Gastrointestinal - Inflammatory bowel disease
ACTRN12621000168853Monash University - Central Clinical School41
已完成
不适用
Optimized Response Assessment of Gastrointestinal Stromal Tumors Using Dual-Energy CT: A Prospective Multicenter-Multinational Trail in Patients Undergoing Targeted Therapy with a tyrosine-kinase-inhibitorC16C17C18Malignant neoplasm of stomachMalignant neoplasm of small intestineMalignant neoplasm of colon
DRKS00008173niversitätsklinikum Mannheim138